| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1116.602/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602 |
| Version | 20240703 |
| Status | active |
| Date | 2024-07-03T01:06:58-04:00 |
| Name | Neurokinin1ReceptorAntagonist |
| Title | Neurokinin 1 Receptor Antagonist |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medication for Neurokinin 1 Receptor Antagonist.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for Neurokinin 1 Receptor Antagonist: rolapitant, aprepitant, fosnetupitant palonosetron, netupitant palonosetron, fosaprepitant),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
No resources found
| CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm  | RxNorm |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222 | Aprepitant Oral |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223 | Fosaprepitant Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560 | Rolapitant Oral |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144 | Netupitant Palonosetron Oral |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.145 | Fosnetupitant Palonosetron Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146 | Aprepitant Injectable |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147 | Rolapitant Injectable |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1116.602",
"meta" : {
"versionId" : "17",
"lastUpdated" : "2024-07-03T01:06:58.000-04:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "American Society of Clinical Oncology Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-10-09"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-07-03"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1116.602"
}
],
"version" : "20240703",
"name" : "Neurokinin1ReceptorAntagonist",
"title" : "Neurokinin 1 Receptor Antagonist",
"status" : "active",
"date" : "2024-07-03T01:06:58-04:00",
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medication for Neurokinin 1 Receptor Antagonist.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for Neurokinin 1 Receptor Antagonist: rolapitant, aprepitant, fosnetupitant palonosetron, netupitant palonosetron, fosaprepitant),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.145"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:2009e8a6-2e55-4882-90e6-ea9aa2a90133",
"timestamp" : "2024-12-10T06:22:00-05:00",
"total" : 15,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1552343",
"display" : "netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1665503",
"display" : "rolapitant 90 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1729308",
"display" : "aprepitant 125 MG Powder for Oral Suspension"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1731075",
"display" : "fosaprepitant 115 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1731077",
"display" : "fosaprepitant 150 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1986885",
"display" : "92.5 ML rolapitant 1.8 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1995150",
"display" : "18 ML aprepitant 7.2 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2044429",
"display" : "fosnetupitant 235 MG / palonosetron 0.25 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2374366",
"display" : "20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2631783",
"display" : "4.4 ML aprepitant 7.2 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "2664065",
"display" : "50 ML fosaprepitant 3 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "403810",
"display" : "aprepitant 80 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "403811",
"display" : "aprepitant 125 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "644088",
"display" : "aprepitant 40 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "754508",
"display" : "{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.